Breast Cancer Biomarker Analysis- OptraSCAN Inc

Posted by OptraSCAN inc on February 16th, 2022

Breast Cancer is a very common form of cancer among women that causes an unfavorable effect if left neglected for a long time.

OptraSCAN offers breast cancer biomarker analysis technology. Our Breast Carcinoma Analysis Solution aims at analyzing and interpreting breast carcinoma images to identify and quantify tumors.

Along with identifying tumor clusters, it also focuses on and measures areas of invasive carcinoma and DCIS (Ductal Carcinoma In Situ). Some of the areas that could be quantified include the total tissue area, tumor area as well as invasive cellularity.

This acts as a companion diagnostic tool to help the pathologist in making decisions & above identifications, which otherwise could be greatly challenging and time-consuming.

Features:

• Evaluates tumor (invasive carcinoma) area and the tissue area
• Automated evaluation of invasive cellularity in the tumor area
• Identifies DCIS

Tel: +1-408-524-5300

Contact us at- info@optrascan.com

Read more about- Digital Histology Solutions